VM
TXMD icon

VHCP Management’s TherapeuticsMD TXMD Stock Holding History

VHCP Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,930
Closed -$5.12M – 19
2015
Q1 		$5.12M Hold
16,930
– – 1.18% 15
2014
Q4 		$3.77M Hold
16,930
– – 1.04% 17
2014
Q3 		$3.93M Hold
16,930
– – 1.77% 13
2014
Q2 		$3.74M Hold
16,930
– – 2% 14
2014
Q1 		$5.34M Hold
16,930
– – 2.78% 11
2013
Q4 		$4.41M Buy
+16,930
New +$3.71M 2.37% 13

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VHCP Management's TXMD Position: Q2 2015 in Review

VHCP Management sold out of TherapeuticsMD (TXMD) in Q2 2015, closing a stake of 16,930 shares — an estimated $5.12M sold.

VHCP Management first reported a position in TXMD in Q4 2013 and held it in 6 quarters. The position peaked at $5.34M in Q1 2014. 115 funds tracked by Wall St. Rank hold TXMD as of Q2 2015.

  • VHCP Management reported no remaining TherapeuticsMD position as of Q2 2015 after selling out during the quarter.
  • VHCP Management sold 16,930 TherapeuticsMD shares in Q2 2015, an estimated $5.12M.
  • VHCP Management first reported a position in TherapeuticsMD in Q4 2013 and held it in 6 quarters.
  • VHCP Management's TherapeuticsMD position peaked at $5.34M in Q1 2014.
  • 115 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2015.

Based on VHCP Management's 13F filing for Q2 2015, filed 13 Aug 2015.